Withdrawal of antiparkinson drugs.
D001712:Biperiden / Q000627:therapeutic use; D002090:Butyrophenones / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000150:complications* / Q000188:drug therapy; D012008:Recurrence; D013888:Thiothixene / Q000627:therapeutic use; D013997:Time Factors; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014282:Trihexyphenidyl / Q000627:therapeutic use
D002090:Butyrophenones; D010276:Parasympatholytics; D014149:Tranquilizing Agents; D001712:Biperiden; D014282:Trihexyphenidyl; D013888:Thiothixene